Antibody Structure: A Complete Guide to Regions, Domains, and Immunoglobulin Classes

Antibodies are the most widely used affinity reagents in biomedical research. Whether you are selecting an antibody for Western blot, flow cytometry, or IHC, understanding antibody structure helps you make better decisions about clonality, host species, isotype, and conjugation. This guide covers the structural organization of immunoglobulins from the overall Y-shaped architecture down to individual domains and functional regions.

1. Overall Antibody Architecture

An antibody (also called an immunoglobulin, abbreviated Ig) is a large, Y-shaped glycoprotein with a molecular weight of approximately 150 kDa for IgG. The molecule consists of four polypeptide chains: two identical heavy chains (~50 kDa each) and two identical light chains (~25 kDa each), held together by interchain disulfide bonds and non-covalent interactions.

The Y-shape creates three functional segments: two identical Fab arms (Fragment, antigen-binding) that recognize and bind the target antigen, and one Fc stem (Fragment, crystallizable) that interacts with immune cells and complement proteins to mediate effector functions. The two Fab arms and the Fc stem are connected by a flexible hinge region that allows the Fab arms to move independently, accommodating antigens at different distances on a cell surface.

2. Heavy and Light Chains

The N-terminus of both chains is where antigen binding occurs — this is the variable region that differs between antibodies and gives each antibody its unique specificity. The C-terminus of the heavy chain forms the constant region that defines the antibody class and determines how the immune system responds after the antibody binds its target.

3. Fab Region: Antigen Binding

Each Fab arm consists of the complete light chain (VL + CL) paired with the VH and CH1 domains of the heavy chain. The Fab region contains the antigen-binding site (paratope), formed by the complementarity-determining regions (CDRs) of both VH and VL domains. Each antibody has two identical Fab arms, meaning it can bind two copies of the same antigen simultaneously (bivalent binding).

In the laboratory, Fab fragments can be generated by enzymatic digestion with papain, which cleaves the antibody above the hinge region, producing two Fab fragments and one Fc fragment. Fab fragments are commonly used in research when Fc-mediated effects (such as Fc receptor binding or complement activation) need to be avoided — for example, in blocking experiments or when staining Fc receptor-rich cells like macrophages. For more on how Fc receptor binding causes background in antibody-based assays, see our Isotype Controls Guide.

4. Fc Region: Effector Functions

The Fc region is formed by the CH2 and CH3 domains of both heavy chains and is responsible for the "downstream" biological activities of the antibody after antigen binding. Key Fc-mediated functions include: binding to Fc receptors (FcRs) on immune cells to trigger phagocytosis, ADCC (antibody-dependent cellular cytotoxicity), or degranulation; activating the classical complement pathway via C1q binding; and controlling antibody half-life through interaction with the neonatal Fc receptor (FcRn), which rescues IgG from lysosomal degradation and maintains its long serum half-life (~21 days for human IgG1).

In research, the Fc region is relevant when choosing secondary antibodies — the secondary antibody's target is the constant region of the primary antibody's heavy chain. For in vivo experiments using therapeutic or blocking antibodies, Fc engineering (e.g., N297A mutation, LALA mutation) is used to silence effector functions while retaining target binding. abinScience offers InVivo-grade antibodies with defined Fc formats for preclinical research.

5. The Hinge Region

The hinge region is a short, flexible segment between the CH1 and CH2 domains of the heavy chain. It connects the Fab arms to the Fc stem and provides the flexibility needed for the two Fab arms to bind antigens at varying distances. The hinge contains the interchain disulfide bonds that link the two heavy chains together.

The hinge is the site where proteases (papain, pepsin) cleave the antibody. Papain cuts above the hinge disulfide bonds, generating Fab + Fc. Pepsin cuts below, generating F(ab')₂ (both Fab arms still linked) + degraded Fc fragments. IgM and IgE lack a defined hinge region and instead have an additional constant domain (CH2 in IgM/IgE corresponds structurally to the hinge in IgG).

6. Variable and Constant Domains

Each antibody chain is composed of repeating structural units called immunoglobulin domains (~110 amino acids each, folded into a characteristic "immunoglobulin fold" of two β-sheets stabilized by an intradomain disulfide bond). These domains are classified as either variable (V) or constant (C):

The variable regions differ between antibodies and determine antigen specificity, while the constant regions are shared among antibodies of the same class and determine effector functions. For a detailed comparison of how variable region residues are numbered across different schemes, see our Kabat vs Chothia vs Martin Numbering Guide.

7. CDRs: The Antigen-Binding Site

Within each variable domain (VH and VL), three short, hypervariable loops called complementarity-determining regions (CDR1, CDR2, CDR3) form the actual contact surface with the antigen. The six CDRs (three from VH + three from VL) together create the paratope — the unique three-dimensional binding pocket that recognizes a specific epitope on the target antigen.

CDR3 of the heavy chain (HCDR3) is the most variable in both length and sequence and typically contributes the most to antigen-binding specificity and affinity. HCDR3 is generated by V-D-J recombination (with junctional diversity), while light chain CDR3 is generated by V-J recombination. The regions between CDRs are called framework regions (FR1–FR4), which form the structural scaffold that positions the CDR loops correctly.

In antibody engineering, CDR grafting (transplanting CDRs from one antibody onto a different framework) is the basis of antibody humanization — a process used to reduce immunogenicity of animal-derived therapeutic antibodies. For research antibodies, understanding CDR-mediated binding is important when evaluating antibody specificity and cross-reactivity between species.

8. Immunoglobulin Classes (IgG, IgM, IgA, IgD, IgE)

The five immunoglobulin classes are defined by the heavy chain constant region. Each class has distinct structural features and biological functions:

In research, IgG is the predominant isotype used for antibody reagents. When a product datasheet lists "isotype: mouse IgG1, kappa," this tells you the heavy chain class (IgG1, determining Fc properties) and light chain type (kappa). This information is essential for selecting the correct secondary antibody and isotype control.

9. Antibody Fragments Used in Research

abinScience offers XtenNano® Nanobodies (VHH) for research applications requiring small-format antibodies with excellent tissue penetration and stability.

10. How Structure Affects Your Experiment

References

1. Janeway CA Jr, Travers P, Walport M, et al. Immunobiology: The Immune System in Health and Disease. 5th edition. New York: Garland Science; 2001. NCBI Bookshelf

2. Vidarsson G, Dekkers G, Rispens T. IgG subclasses and allotypes: from structure to effector functions. Front Immunol. 2014;5:520. doi: 10.3389/fimmu.2014.00520

3. Chiu ML, Gilliland GL. Engineering antibody therapeutics. Curr Opin Struct Biol. 2016;38:163-173. doi: 10.1016/j.sbi.2016.07.012

This article is provided for educational purposes only. For technical support, contact info@abinscience.com.